Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Eli Lilly announces executive restructuring

Eli Lilly announces executive restructuring

23rd May 2008

Eli Lilly has announced a range of changes in its executive leadership structure as it aims to reduce bureaucracy and streamline decision-making processes.

President and chief executive officer of the firm John Lechleiter states that the number of layers of management will be reduced and existing roles will be clarified.

“These changes represent important elements in enabling the implementation of our strategy. In some cases, they have resulted in staffing changes, with new leaders in key roles,” he adds.

Alan Breier, chief medical officer and vice-president of medical, will leave the company to take up a post at the Indiana University school of medicine and Tim Franson, vice-president of regulatory affairs will retire after 22 years with the firm.

Tim Garnett, presently the vice-president of global patient safety, will take over the role of vice-president and chief medical officer.

In related news, Reuters recently reported that has made a donation of $1 million (500,000 pounds) to allow doctors to access a web-based refresher course on tuberculosis.

We currently have 7 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.